Medical research

Clinical trials: Two arms are better than one

The German Institute for Quality and Efficiency in Health Care (IQWiG) has responded critically to a reflection paper by the European Medicines Agency (EMA) on the approval of new drugs based on single-arm studies.

Medications

New drug for vaginal yeast infections approved by FDA

(HealthDay)—A new and expensive antifungal drug to treat vaginal yeast infections was approved by the U.S. Food and Drug Administration this week, but critics say it is not needed.

Medications

FDA panel: Expand use of fish oil drug Vascepa

Approved use of the prescription-strength fish oil drug Vascepa should be widened to include more patients at risk for heart attack and stroke, a U.S. Food and Drug Administration advisory panel recommended Thursday.

page 9 from 18